Immuno-oncology therapy developer Lava Therapeutics has filed for a $100m IPO, having been set up in 2016 to exploit Amsterdam University Medical Centers research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Funds managed by BlackRock added $40m to the $60m supplied for the drug development technology developer by investors including Novo, Evotec and Bristol Myers Squibb in May.

Biox Biosciences, Novo, Sanofi and Merck & Co are all in line to exit the immuno-oncology therapy developer, which has filed for a $100m initial public offering.

BlackRock has joined the University of Dundee spinout’s series C round, following a $60m first close in May last year.

Sage participated in a $12.6m round for the business banking and accounting software provider that took its total funding above $21m.

Q&A with Nicolas Autret, investment director, Samsung Catalyst Fund

SoftBank Vision Fund had provided $1.45bn of funding for the supply chain financier, which is reportedly preparing for insolvency.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

WeGift has boosted its series A-plus round to $12m with a $4m investment by Commerzbank's venture capital arm.